Multiple Helicobacter pylori proteins and membranes (H. pylori proteins/membranes)

Helicobacter pylori is a Gram-negative, spiral-shaped bacterium that colonizes the human stomach, leading to chronic gastritis, peptic ulcers, and gastric cancer (Kusters et al., 2006). The target "Multiple Helicobacter pylori proteins and membranes" refers to the collective structural and functional components of the bacterium that are susceptible to antimicrobial agents. Key proteins include urease, which allows the bacteria to survive the acidic gastric environment by producing ammonia, and virulence factors such as VacA and CagA that disrupt host cell signaling (StatPearls, 2023). The bacterial membranes and cell wall provide structural integrity and are the primary targets for beta-lactam antibiotics like amoxicillin (NIH, 2022). Bismuth-based compounds are particularly notable for their multi-targeted action, as they bind to the bacterial cell wall and inhibit various cytoplasmic enzymes, leading to bacterial lysis (PubChem, 2024). Effective treatment typically requires a combination of drugs to overcome the bacterium's diverse defense mechanisms and prevent the development of antibiotic resistance.

Other names

Helicobacter pylori proteomeH. pylori cell envelopeH. pylori antigensHelicobacter pylori cellular components

Drugs targeting these components act through various mechanisms: bismuth salts disrupt the bacterial cell wall and inhibit enzymes like urease; beta-lactams inhibit cell wall synthesis; macrolides and tetracyclines inhibit protein synthesis; and nitroimidazoles cause DNA strand breakage (StatPearls, 2023; PubChem, 2024).